These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32341642)

  • 1. Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease.
    Almagro P; Boixeda R; Diez-Manglano J; Gómez-Antúnez M; López-García F; Recio J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():755-764. PubMed ID: 32341642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the relationship between COPD and CVD: what are the implications for clinical practice?
    Morgan AD; Zakeri R; Quint JK
    Ther Adv Respir Dis; 2018; 12():1753465817750524. PubMed ID: 29355081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing comorbidities in COPD.
    Hillas G; Perlikos F; Tsiligianni I; Tzanakis N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():95-109. PubMed ID: 25609943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice.
    Maeda T; Dransfield MT
    Curr Opin Pulm Med; 2024 Mar; 30(2):141-149. PubMed ID: 38085609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese expert consensus on the management of cardiovascular comorbidities in patients with chronic obstructive pulmonary disease].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1180-1191. PubMed ID: 36480848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Morbidity in Individuals with Impaired FEV1.
    Mathew J; Nickel NP
    Curr Cardiol Rep; 2022 Mar; 24(3):163-182. PubMed ID: 35038132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease in HIV.
    Byanova K; Kunisaki KM; Vasquez J; Huang L
    Expert Rev Respir Med; 2021 Jan; 15(1):71-87. PubMed ID: 33167728
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics.
    Brassington K; Selemidis S; Bozinovski S; Vlahos R
    Clin Sci (Lond); 2022 Mar; 136(6):405-423. PubMed ID: 35319068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease.
    Alderawi A; Caramori G; Baker EH; Hitchings AW; Rahman I; Rossios C; Adcock I; Cassolari P; Papi A; Ortega VE; Curtis JL; Dunmore S; Kirkham P
    BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33208304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Crisan L; Wong N; Sin DD; Lee HM
    Front Cardiovasc Med; 2019; 6():79. PubMed ID: 31294030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary comorbidities in cardiac rehabilitation.
    Bauldoff GS; Carlin BW
    Prog Cardiovasc Dis; 2022; 70():190-194. PubMed ID: 35151694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Swedish CArdioPulmonary BioImage Study: objectives and design.
    Bergström G; Berglund G; Blomberg A; Brandberg J; Engström G; Engvall J; Eriksson M; de Faire U; Flinck A; Hansson MG; Hedblad B; Hjelmgren O; Janson C; Jernberg T; Johnsson Å; Johansson L; Lind L; Löfdahl CG; Melander O; Östgren CJ; Persson A; Persson M; Sandström A; Schmidt C; Söderberg S; Sundström J; Toren K; Waldenström A; Wedel H; Vikgren J; Fagerberg B; Rosengren A
    J Intern Med; 2015 Dec; 278(6):645-59. PubMed ID: 26096600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk.
    Amegadzie JE; Sadatsafavi M
    Eur Respir J; 2023 Aug; 62(2):. PubMed ID: 37652564
    [No Abstract]   [Full Text] [Related]  

  • 14. Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation.
    Valenzuela PL; Ruilope LM; Santos-Lozano A; Wilhelm M; Kränkel N; Fiuza-Luces C; Lucia A
    Eur Heart J; 2023 Jun; 44(21):1874-1889. PubMed ID: 37005351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial fat in patients with chronic obstructive pulmonary disease as a marker of high cardiovascular risk - review.
    Sova M; Genzor S; Kolek V; Čtvrtlík F; Asswad AG; Zela O; Tauber Z
    Adv Respir Med; 2018 Dec; ():. PubMed ID: 30595000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender dimension in cardio-pulmonary continuum.
    Hernandez L; Laucyte-Cibulskiene A; Ward LJ; Kautzky-Willer A; Herrero MT; Norris CM; Raparelli V; Pilote L; Stenvinkel P; Kublickiene K;
    Front Cardiovasc Med; 2022; 9():916194. PubMed ID: 36003909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mind the Gap: Addressing Cardiovascular Disease in Chronic Obstructive Pulmonary Disease.
    Wells JM; Payne GA
    Ann Am Thorac Soc; 2022 Jul; 19(7):1093-1095. PubMed ID: 35772101
    [No Abstract]   [Full Text] [Related]  

  • 18. Exacerbating the burden of cardiovascular disease: how can we address cardiopulmonary risk in individuals with chronic obstructive pulmonary disease?
    Shrikrishna D; Taylor CJ; Stonham C; Gale CP
    Eur Heart J; 2024 Jan; 45(4):247-249. PubMed ID: 37832033
    [No Abstract]   [Full Text] [Related]  

  • 19. COPD makes CHIP less indeterminate.
    Huls G
    Blood; 2022 Jan; 139(3):310-311. PubMed ID: 35050339
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Decoding complexity: new insights into the cellular and molecular mechanisms of cardiovascular and metabolic diseases.
    Liu CF; Gulshan K; Basu J; Sun YY
    Front Cardiovasc Med; 2023; 10():1239170. PubMed ID: 37492156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.